Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Columbia Laboratories Inc repurchases 1.4 mln shares of common stock from Actavis Inc's Coventry Acquisition, LLC

Friday, 7 Mar 2014 06:50am EST 

Columbia Laboratories Inc:Repurchases 1.4 mln shares of its common stock, par value $0.01 per share.From Coventry Acquisition, LLC, subsidiary of Actavis Inc. (Actavis), at $6.08 per share.Represents a 10.75 pct discount to closing price on March 6.Total purchase price was about $8.5 mln.This transaction reduces total issued and outstanding shares of common stock by about 11.5 pct from about 12.15 mln to 10.75 mln. 

Company Quote

0.01 +0.17%
12:42pm EDT